These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3779514)

  • 1. Metabolism and disposition of 3,6-dibutanoylmorphine in rat brain.
    Tasker RA; Nakatsu K
    Can J Physiol Pharmacol; 1986 Sep; 64(9):1160-3. PubMed ID: 3779514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine diesters. II. Blood metabolism and analgesic activity in the rat.
    Owen JA; Nakatsu K
    Can J Physiol Pharmacol; 1984 Apr; 62(4):452-6. PubMed ID: 6733592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 3,6-dibutanoylmorphine as an analgesic in vivo: comparison with morphine and 3,6-diacetylmorphine.
    Tasker RA; Nakatsu K
    Life Sci; 1984 Apr; 34(17):1659-67. PubMed ID: 6727542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantitation of morphine, monobutanoylmorphine and dibutanoylmorphine using short capillary column gas chromatography-mass spectrometry.
    Tasker RA; Nakatsu K
    Analyst; 1986 May; 111(5):563-5. PubMed ID: 3740426
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative cataleptic potency of narcotic analgesics, including 3,6-dibutanoylmorphine and 6-monoacetylmorphine.
    Tasker RA; Vander Velden PL; Nakatsu K
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):747-50. PubMed ID: 6543399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct nose-to-brain transfer of morphine after nasal administration to rats.
    Westin UE; Boström E; Gråsjö J; Hammarlund-Udenaes M; Björk E
    Pharm Res; 2006 Mar; 23(3):565-72. PubMed ID: 16489488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenously administered nicomorphine and its metabolites in man.
    Koopman-Kimenai PM; Vree TB; Booij LH; Dirksen R; Nijhuis GM
    Eur J Anaesthesiol; 1993 Mar; 10(2):125-32. PubMed ID: 8462537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu receptor binding of some commonly used opioids and their metabolites.
    Chen ZR; Irvine RJ; Somogyi AA; Bochner F
    Life Sci; 1991; 48(22):2165-71. PubMed ID: 1851921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of morphine glucuronide metabolites in morphine dependence in the rat.
    Salem A; Hope W
    Pharmacol Biochem Behav; 1997 Aug; 57(4):801-7. PubMed ID: 9259009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and O-dealkylation of morphine-3-alkyl ethers in the rat. A radioimmunoassay study.
    Butz RF; Jones EC; Welch RM; Findlay JW
    Drug Metab Dispos; 1983; 11(5):481-8. PubMed ID: 6138235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate receptor binding of nicomorphine and its hydrolysis products in rat brain.
    Lobbezoo MW; Van Rooy HH; Van Wijngaarden I; Soudijn W
    Eur J Pharmacol; 1982 Aug; 82(3-4):207-11. PubMed ID: 6290237
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of the affinity ligands 14-beta-chloroacetylnaltrexone and 14-beta-bromoacetamidomorphine on [3H]-dihydromorphine binding sites in rat brain.
    Reichman M; Dirksen R; Abood LG; Gala D
    Biochem Pharmacol; 1986 Nov; 35(22):3995-8. PubMed ID: 3022745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of morphine and morphine metabolites in rat brain.
    Bullock P; Spanner S; Ansell GB
    Biochem Soc Trans; 1977; 5(1):166-8. PubMed ID: 892148
    [No Abstract]   [Full Text] [Related]  

  • 14. The disposition of morphine and its metabolites in the in-situ rat isolated perfused liver.
    Evans AM; Shanahan K
    J Pharm Pharmacol; 1995 Apr; 47(4):333-9. PubMed ID: 7791033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy.
    Temsamani J; Bonnafous C; Rousselle C; Fraisse Y; Clair P; Granier LA; Rees AR; Kaczorek M; Scherrmann JM
    J Pharmacol Exp Ther; 2005 May; 313(2):712-9. PubMed ID: 15647327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides in rabbits receiving single and repeated doses of morphine.
    Mignat C; Jansen R; Ziegler A
    J Pharm Pharmacol; 1995 Feb; 47(2):171-5. PubMed ID: 7602474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic use of heroin: a review of the pharmacological literature.
    Sawynok J
    Can J Physiol Pharmacol; 1986 Jan; 64(1):1-6. PubMed ID: 2420426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
    Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
    Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical reactivity of morphine and morphine-6-conjugates and their binding to rat brain.
    Yoshimura H; Natsuki R; Ida S; Oguri K
    Chem Pharm Bull (Tokyo); 1976 May; 24(5):901-6. PubMed ID: 1021274
    [No Abstract]   [Full Text] [Related]  

  • 20. Further metabolic studies of codeine and morphine in mice pretreated with sympathomimetics.
    Dambisya YM; Chan K; Wong CL
    Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):773-80. PubMed ID: 1297894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.